Insights Widest with the analysis, Proactive gives perspectives that others don't.

MINDMED LSD MindMed seeks to harvest the power of psychedelics to treat mental health disorders

The New York City-based company has several projects in various stages from planning to ongoing...

4 days, 18 hours ago
Deep dive

Cardiol Therapeutics is advancing its proprietary pharmaceutical cannabidiol...

The company is expecting significant growth in the second half of 2020 as it moves to launch its...

4 days, 19 hours ago

Proactive virtual event to showcase four companies on the fast track to...

Algernon Pharmaceuticals, Clean Seed Capital, MamaMancini's Holdings, and Alpine 4 Technologies...

1 week, 1 day ago

Small cap growth stocks in the spotlight at Proactive’s virtual event on July 21

Joining Proactive this time out are environmental engineering company BioLargo; life sciences...

2 weeks, 1 day ago


CytoDyn addresses negative claims made by healthcare publication STAT on its...

CytoDyn (OTCQB:CYDY) CEO Nader Pourhassan spoke to Proactive, addressing negative claims made by healthcare publication STAT on its coronavirus study. Pourhassan says the company has released what he says are positive results from its coronavirus treatment clinical study, and explains why he...

3 days, 15 hours ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.